We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RGLD:NASDAQRoyal Gold, Inc. Analysis

Data as of 2026-06-05 - not real-time

$206.07

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Royal Gold delivered a record first‑quarter revenue surge and a sharp rise in operating cash flow, underscoring the impact of recent acquisitions and higher metal prices. Margins remain exceptionally strong, with gross and operating margins well above industry averages. The company’s dividend yield, while modest, is backed by a low payout ratio, suggesting sustainability. A discounted cash‑flow model places fair value well above the current market price, implying significant upside potential. Technically, the stock is trading just below its short‑term moving average and near a key support level, with the relative strength index indicating oversold conditions. The MACD histogram remains in bearish territory, hinting at short‑term downside pressure. Volatility is elevated and beta exceeds unity, reflecting sensitivity to broader market swings and commodity price movements, while the fear‑and‑greed index signals extreme greed in the market.
Given the combination of strong fundamentals, attractive valuation gap, and a sustainable dividend, the equity appears fundamentally undervalued. The sector exposure to gold provides a defensive tilt, though commodity and geographic diversification introduce moderate risk. Liquidity is adequate despite a recent decline in volume, and regulatory risk remains low. For investors, the profile aligns with a blend of growth and value characteristics. A cautious short‑term buy stance is warranted, with higher conviction for medium‑ and long‑term ownership. The upside potential, coupled with a resilient cash‑flow base, supports a positive outlook. Overall, the stock merits a buy recommendation across horizons, with confidence tempered by short‑term technical weakness.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • oversold RSI
  • price near support
  • declining volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • valuation gap
  • sustainable dividend
  • strong cash flow

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • gold exposure defensive
  • growth/value blend
  • long‑term upside

Key Metrics & Analysis

Financial Health

Revenue Growth143.00%
Profit Margin48.91%
P/E Ratio24.9
ROE11.98%
ROA8.10%
Debt/Equity7.98
P/B Ratio2.4
Op. Cash Flow$862.0M
Free Cash Flow$-409444384

Technical Analysis

TrendNeutral
RSI33.0
Support$205.59
Resistance$247.19
MA 20$226.30
MA 50$240.94
MA 200$226.82
MACDBearish
VolumeDecreasing
Fear & Greed Index83.5

Valuation

Fair Value$252.59
Target Price$331.67
Upside/Downside60.95%
GradeUndervalued
TypeBlend
Dividend Yield0.86%

Risk Assessment

Beta1.21
Volatility40.10%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.